Form D · Pharmaceuticals
CYTOMETIX INC
Milwaukee, WI · CIK 0001427524
Offering snapshot reported Jul 16, 2010 · SEC filing
- Reported sold
- $1.91M Offering amount: $2M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Jul 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2010 | Initial | $1,910,000 | No comparison | 23 | SEC filing |
| Feb 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145145
Source: Form D, filed Jul 16, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lane Brostrom | Director, Executive |
| Frank Castellana | Director |
| Eckhart Grohmann | Director |
| David Harder | Director, Executive |
| John Luellwitz | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
756 North Milwaukee Street Suite 250
Milwaukee, WI, 53202
Milwaukee, WI, 53202